share_log

四環醫藥:截至二零二四年二月二十九日止之股份發行人的證券變動月報表

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 1 03:02
Summary by Moomoo AI
四環醫藥(四環医药)於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的公司股份變動情況。報告顯示,四環醫藥的法定/註冊股本及已發行股份在2月份均無變動,維持在1,000,000,000港元及9,329,999,206股。此外,根據2017年10月24日採納的股份期權計劃,公司本月底結存的股份期權數目為74,110,000股,並無新增股份期權發行。四環醫藥確認,所有證券發行均已獲得董事會批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
四環醫藥(四環医药)於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的公司股份變動情況。報告顯示,四環醫藥的法定/註冊股本及已發行股份在2月份均無變動,維持在1,000,000,000港元及9,329,999,206股。此外,根據2017年10月24日採納的股份期權計劃,公司本月底結存的股份期權數目為74,110,000股,並無新增股份期權發行。四環醫藥確認,所有證券發行均已獲得董事會批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
Four Circle Pharmaceuticals (4 Circle Pharmaceuticals) filed with Hong Kong Trading and Settlement Limited on 1 March 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's shares for the year ended 29 February 2024. The report showed that the regulated/registered share capital and issued shares of Four Circle Pharmaceuticals remained unchanged in February at HK$1,000,000,000 and 9,329,999,206 shares. In addition, under the share option plan adopted on October 24, 2017, the Company had 74,110,000 shares outstanding at the end of this month and no additional share options were issued. Four Circles Pharmaceuticals confirms that all securities issuance has been approved by the Board of Directors and complies with the relevant requirements of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited.
Four Circle Pharmaceuticals (4 Circle Pharmaceuticals) filed with Hong Kong Trading and Settlement Limited on 1 March 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's shares for the year ended 29 February 2024. The report showed that the regulated/registered share capital and issued shares of Four Circle Pharmaceuticals remained unchanged in February at HK$1,000,000,000 and 9,329,999,206 shares. In addition, under the share option plan adopted on October 24, 2017, the Company had 74,110,000 shares outstanding at the end of this month and no additional share options were issued. Four Circles Pharmaceuticals confirms that all securities issuance has been approved by the Board of Directors and complies with the relevant requirements of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more